[Failure of therapy with thrombocyte concentrates as a sequela of anti-Kob (3b) antibodies in a patient].
The report deals with a failure in transfusing thrombocyte concentrates in a patient affected with bone-marrow hypoplasia caused by thrombocyte antibodies with anti-Kob (3b) specificity. This is referred to as a rare occurrence since, in general, HLA cytotoxins are identified as underlying cause and polyspecific or anti-Zwa(P1A1) antibodies only in exceptional cases.